Supernus Pharmaceuticals, Inc. (SUPN)
51.27
-0.03
(-0.06%)
USD |
NASDAQ |
Feb 10, 10:09
Supernus Pharmaceuticals Accounts Payable (Quarterly) : 8.177M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 432.00M |
| Catalyst Pharmaceuticals, Inc. | 9.096M |
| Vertex Pharmaceuticals, Inc. | 420.30M |
| Krystal Biotech, Inc. | 2.097M |
| Moderna, Inc. | 267.00M |